CONMED CORPORATION Treasury Stock, Common, Shares
CONMED CORPORATION (CNMD) had Treasury Stock, Common, Shares of 1.31 million shares as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-07-29
- 2026-06-30: Treasury Stock, Common, Shares 1.31M shares.
- 2025-12-31: Treasury Stock, Common, Shares 328.10K shares.
- 2025-09-30: Treasury Stock, Common, Shares 344.14K shares.
- 2025-06-30: Treasury Stock, Common, Shares 352.90K shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 1.31M shares 10-Q · filed 2026-07-29 |
| 2025-12-31 | 328.10K shares 10-Q · filed 2026-07-29 |
| 2025-09-30 | 344.14K shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 352.90K shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 369.43K shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 397.86K shares 10-K · filed 2026-02-17 |
| 2024-09-30 | 414.51K shares 10-Q · filed 2024-10-31 |
| 2024-06-30 | 477.03K shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 508.03K shares 10-Q · filed 2024-04-25 |
| 2023-12-31 | 534.00K shares 10-K · filed 2025-02-18 |
| 2023-09-30 | 552.02K shares 10-Q · filed 2023-10-26 |
| 2023-06-30 | 565.68K shares 10-Q · filed 2023-07-27 |
| 2023-03-31 | 738.72K shares 10-Q · filed 2023-04-27 |
| 2022-12-31 | 811.53K shares 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |